Articles

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the biotechnology company’s vaccines and said it would cancel some contracts and stop funding mRNA drug development.

The new Republican tax law will speed up Social Security’s insolvency, the agency’s chief actuary said.

Home developers are overbuilding the large and underbuilding the small.

“Reciprocal” levies are due to kick in Aug. 7 — with some exceptions.

The government is about to take an unprecedented step toward meeting its financing needs on Thursday by using a single auction to sell a record $100 billion of Treasury bills that mature in four weeks.

While Apple is unlikely to start making iPhones in the U.S., investors seem to think that increased manufacturing commitments more generally could help secure better tariff treatment.

India ranks as the No. 2 importer of Russian oil since Russia’s invasion of Ukraine in February 2022, behind China, according to one research center.

Marcus Lemonis, TV personality and executive chair of Beyond Inc., thinks that a partnership with certain retailers could be a winner for Opendoor

If international investors can afford to hedge their dollar exposure, they are more likely to buy U.S. bonds, one fund-manager said.

There are growing worries at the central bank about an economic slowdown.

While Nvidia dominates in AI GPUs, analysts still see room for AMD to capture a meaningful slice of the market.

The president’s policies are stagflationary, but they cannot derail America’s dynamic private sector.